Axcelis Q3 revenue $176.7M, record implant systems; EPS $0.81, guides Q4 EPS $0.84

AXCELIS TECHNOLOGIES INC

2021-Q3 EPS reported $1.83 revenue$456,744,000

Revenue $176.7M, up 20% QoQ; system revenue record $126.2M.
Net income $27.5M ($0.81 diluted EPS) vs $18.9M ($0.55) Q2.
Gross margin 43.3%, slightly down from 43.5% Q2.
Q4 outlook: revenue ~$190M, EPS ~$0.84; FY 2021 revenue >$640M.
Shipped Purion SiC and high-current implanters to Asia/Europe and memory customers.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.